title: The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular risk.
abstract: This was the timely topic debated by Dr Allan Sniderman (protagonist) and Dr Jacques Genest Jr (antagonist) at the ninth internation symposium on atherosclerosis, October 7, 1991, in Chicago-Rosemont, Illinois. Dr Maurice Mishkel, Professor Emeritus and founder of the McMaster Lipid Research Clinic moderated the event which was made possible by an educational grant from Sandoz Canada.
authors.affiliation: Cardiology Division, Royal Victoria Hospital, Montreal, Quebec.
authors.forename: A D
authors.initials: AD
authors.lastname: Sniderman
mesh_terms: D001055:Apolipoproteins B / Q000032:analysis*; D002170:Canada; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D008055:Lipids / Q000097:blood*; D008403:Mass Screening / Q000379:methods*; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids; D014280:Triglycerides